Nektar Therapeutics (LON:0UNL)
12.54
+0.08 (0.63%)
At close: Jan 31, 2025
Nektar Therapeutics Employees
Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.
Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
1.11M GBP
Profits / Employee
-1.69M GBP
Market Cap
289.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Indivior | 1,051 |
Nektar Therapeutics News
- 27 days ago - Nektar Therapeutics: 2 Data Readouts For REZPEG 2025 Could Establish Further POC - Seeking Alpha
- 4 weeks ago - AMBROSIA & NEKTAR Introduces Premium High-End Organic Food from Greece with a Commitment to Purity and Provenance - GlobeNewsWire
- 2 months ago - Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference - PRNewsWire
- 2 months ago - Nektar therapeutics outlines REZOLVE-AD phase 2b data and financial position for Q2 2025 - Seeking Alpha
- 2 months ago - Nektar Therapeutics (NKTR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Nektar Therapeutics Reports First Quarter 2025 Financial Results - Benzinga
- 2 months ago - Nektar Therapeutics Reports First Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Nektar Therapeutics's Earnings: A Preview - Benzinga